KAPRUVIA 50 micrograms/ml, solution for injection 12 bottles of 1 ml
Active ingredients: Difelikefalin acetate, Difelikefalin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection12 bottles of 1 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KAPRUVIA 50 microgrammes/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 12 flacon(s) en verre de 1 ml
- Marketing authorisation holder
- VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Mar 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60144119CIP75508965CIP133400955089650Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIFÉLIKÉFALINEsolution | 50 microgrammes · 1 mL de solution | FT |
| ACÉTATE DE DIFÉLIKÉFALINEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.